Barclays: Impax Labs-Amneal Pharma Merger Creates A Generics Leader

By: via Benzinga
Impax Laboratories Inc (NASDAQ: IPXL) announced an agreement in October to merge with privately held Amneal Pharma, with 75 percent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.